Epidemiology, etiology, and diagnosis of osteoporosis.

Osteoporosis, a major public health problem, is becoming increasingly prevalent with the aging of the world population. Osteoporosis is a skeletal disorder characterized by compromised bone strength, which predisposes the individual to an increased risk of fractures of the hip, spine, and other skeletal sites. The clinical consequences and economic burden of this disease call for measures to assess individuals who are at high risk to allow for appropriate intervention. Many risk factors are associated with osteoporotic fracture, including low peak bone mass, hormonal factors, the use of certain drugs (eg, glucocorticoids), cigarette smoking, low physical activity, low intake of calcium and vitamin D, race, small body size, and a personal or a family history of fracture. All of these factors should be taken into account when assessing the risk of fracture and determining whether further treatment is required. Because osteoporotic fracture risk is higher in older women than in older men, all postmenopausal women should be evaluated for signs of osteoporosis during routine physical examinations. Radiologic laboratory assessments of bone mineral density generally should be reserved for patients at highest risk, including all women over the age of 65, younger postmenopausal women with risk factors, and all postmenopausal women with a history of fractures. The evaluation of biochemical markers of bone turnover has been useful in clinical research. However, the predictive factor of these measurements is not defined clearly, and these findings should not be used as a replacement for bone density testing. Together, clinical assessment of osteoporotic risk factors and objective measures of bone mineral density can help to identify patients who will benefit from intervention and, thus, can potentially reduce the morbidity and mortality associated with osteoporosis-associated fractures in this population.

[1]  T. Abbott,et al.  Patients with Prior Fractures Have an Increased Risk of Future Fractures: A Summary of the Literature and Statistical Synthesis , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  J. Kanis,et al.  Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report , 1994, Osteoporosis International.

[3]  O. Johnell,et al.  Mortality after osteoporotic fractures , 2004, Osteoporosis International.

[4]  O. Johnell,et al.  Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures , 1996 .

[5]  Dennis M. Black,et al.  Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy , 2002 .

[6]  N. Watts,et al.  Esterified estrogen therapy in postmenopausal women. Relationships of bone marker changes and plasma estradiol to BMD changes: A two-year study , 2000, Menopause.

[7]  R. Eastell,et al.  The Use of Biochemical Markers of Bone Turnover in Osteoporosis , 2000, Osteoporosis International.

[8]  J. Compston Bone density: BMC, BMD, or corrected BMD? , 1995, Bone.

[9]  Richard Eastell,et al.  Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate: greater increases in bone mineral density do not relate to greater decreases in fracture risk. , 2004, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[10]  K. Baek,et al.  Official Positions of the International Society for Clinical Densitometry. , 2005 .

[11]  T. O’Neill The Relationship Between Bone Density and Incident Vertebral Fracture in Men and Women , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[12]  Fran Harris,et al.  Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. , 2002, The American journal of medicine.

[13]  P Burckhardt,et al.  [Epidemiology of osteoporosis]. , 1997, Schweizerische medizinische Wochenschrift.

[14]  P Geusens,et al.  Risk of new vertebral fracture in the year following a fracture. , 2001, JAMA.

[15]  S. Cummings,et al.  Endogenous Hormones and the Risk of Hip and Vertebral Fractures Among Older Women , 1999 .

[16]  Jing Fang,et al.  Variations in hip fracture hospitalization rates among different race/ethnicity groups in New York City. , 2004, Ethnicity & disease.

[17]  Sharmila Majumdar,et al.  Osteoporosis imaging. , 2003, Radiologic clinics of North America.

[18]  S. Cummings,et al.  Body Size and Hip Fracture Risk in Older Women: A Prospective Study , 1997 .

[19]  P. Delmas,et al.  Biochemical markers of bone turnover , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[20]  S. Boonen,et al.  The bone quality framework: determinants of bone strength and their interrelationships, and implications for osteoporosis management. , 2005, Clinical therapeutics.

[21]  A. Chines,et al.  Effect of Combined Risedronate and Hormone Replacement Therapies on Bone Mineral Density in Postmenopausal Women , 2001 .

[22]  S. Cummings,et al.  Body size and hip fracture risk in older women: a prospective study. Study of Osteoporotic Fractures Research Group. , 1997, The American journal of medicine.

[23]  Laura B. Hansen,et al.  Current approaches to the prevention and treatment of postmenopausal osteoporosis. , 2003, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[24]  O. Johnell,et al.  Quality of Life in Patients with Vertebral Fractures: Validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO) , 1999, Osteoporosis International.

[25]  B. Dawson-Hughes,et al.  Smoking increases bone loss and decreases intestinal calcium absorption. , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[26]  C. Christiansen,et al.  Low Body Mass Index Is an Important Risk Factor for Low Bone Mass and Increased Bone Loss in Early Postmenopausal Women , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[27]  M. Mezey,et al.  Differences in outcome between black and white elderly hip fracture patients. , 1987, Journal of chronic diseases.

[28]  C. Cooper,et al.  Long-term efficacy of risedronate: a 5-year placebo-controlled clinical experience. , 2003, Bone.

[29]  P. Delmas,et al.  Independent predictors of all osteoporosis-related fractures in healthy postmenopausal women: the OFELY study. , 2003, Bone.

[30]  P. Lips,et al.  Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. , 2001, Endocrine reviews.

[31]  J. Peipert,et al.  Screening for Osteoporosis in Postmenopausal Women: Recommendations and Rationale , 2002, Annals of Internal Medicine.

[32]  E. Barrett-Connor,et al.  Prediction of Fracture Risk in Postmenopausal White Women With Peripheral Bone Densitometry: Evidence From the National Osteoporosis Risk Assessment , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[33]  Ego Seeman,et al.  The structural and biomechanical basis of the gain and loss of bone strength in women and men. , 2003, Endocrinology and metabolism clinics of North America.

[34]  Harry K. Genant,et al.  Interim Report and Recommendations of the World Health Organization Task-Force for Osteoporosis , 1999, Osteoporosis International.

[35]  C. Cooper,et al.  Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. , 2003, Arthritis and rheumatism.

[36]  O. Johnell,et al.  Epidemiology of osteoporotic fractures , 2005, Osteoporosis International.

[37]  M. Law,et al.  A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect , 1997, BMJ.

[38]  J. Eisman,et al.  Osteoporosis in Elderly Men and Women: Effects of Dietary Calcium, Physical Activity, and Body Mass Index , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[39]  S. Christakos,et al.  Primer on the metabolic bone diseases and disorders of mineral metabolism , 1994 .

[40]  S. Cummings,et al.  Bone density at various sites for prediction of hip fractures , 1993, The Lancet.

[41]  R. Eastell,et al.  Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. , 1995, Annals of the rheumatic diseases.

[42]  P. Delmas,et al.  Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[43]  P. Miller Management of osteoporosis. , 1999, Disease-a-month : DM.

[44]  J Pearson,et al.  Prevalent Vertebral Deformities Predict Hip Fractures and New Vertebral Deformities but Not Wrist Fractures , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[45]  B. Lawrence Riggs,et al.  Osteoporosis : etiology, diagnosis, and management , 1988 .

[46]  Rees,et al.  Monoclonal antibody assay for measuring bone-specific alkaline phosphatase activity in serum. , 1995, Clinical chemistry.

[47]  D. Kiel,et al.  Risk Factors for Longitudinal Bone Loss in Elderly Men and Women: The Framingham Osteoporosis Study , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[48]  S. Cummings,et al.  Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group. , 1998, The New England journal of medicine.

[49]  R. Eastell,et al.  Relationship of Early Changes in Bone Resorption to the Reduction in Fracture Risk With Risedronate , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[50]  S. Cummings,et al.  Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. , 1995, The New England journal of medicine.

[51]  M. Seibel Biochemical markers of bone remodeling. , 2003, Endocrinology and metabolism clinics of North America.

[52]  M. Seibel,et al.  Serum tartrate-resistant acid phosphatase 5b is a specific and sensitive marker of bone resorption. , 2001, Clinical chemistry.

[53]  O. Johnell,et al.  An Assessment Tool for Predicting Fracture Risk in Postmenopausal Women , 2001, Osteoporosis International.

[54]  J. Brody,et al.  Sex-specific and race-specific hip fracture rates. , 1990, American journal of public health.

[55]  Susan R. Johnson,et al.  Osteoporosis prevention, diagnosis, and therapy. , 2001, JAMA.

[56]  S. Cummings,et al.  Epidemiology and outcomes of osteoporotic fractures , 2002, The Lancet.

[57]  S. Manolagas,et al.  Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. , 2000, Endocrine reviews.

[58]  H. Rodbard,et al.  American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003. , 2003, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[59]  E. Itoi,et al.  Impact of postural deformities and spinal mobility on quality of life in postmenopausal osteoporosis , 2003, Osteoporosis International.

[60]  D. Shelton,et al.  Radiologic bone assessment in the evaluation of osteoporosis. , 2002, American family physician.

[61]  R. Recker,et al.  AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE PREVENTION AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS: 2001 EDITION, WITH SELECTED UPDATES FOR 2003* AACE Osteoporosis Task Force Chairmen , 2003 .

[62]  V. Gilsanz,et al.  Establishment of peak bone mass. , 2003, Endocrinology and metabolism clinics of North America.

[63]  S. Sun,et al.  Tartrate-resistant acid phosphatase isoform 5b as serum marker for osteoclastic activity. , 2001, Clinical chemistry.

[64]  Jacques P. Brown,et al.  The impact of incident vertebral and non-vertebral fractures on health related quality of life in postmenopausal women , 2002, BMC musculoskeletal disorders.

[65]  J. Bigby Harrison's Principles of Internal Medicine , 1988 .

[66]  P. Miller,et al.  Discordance in patient classification using T-scores. , 1999, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[67]  Volker Kuhn,et al.  Can Novel Clinical Densitometric Techniques Replace or Improve DXA in Predicting Bone Strength in Osteoporosis at the Hip and Other Skeletal Sites? , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[68]  K. Usadel,et al.  Validation of a new automated immunoassay for measurement of intact osteocalcin. , 2002, Clinical laboratory.

[69]  Anders Isaksson,et al.  Biochemical Markers of Bone Metabolism and Prediction of Fracture in Elderly Women , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.